keyword
https://read.qxmd.com/read/38328856/targeting-ccr4-with-mogamulizumab-in-refractory-cd3-cd4-lymphocytic-variant-hypereosinophilic-syndrome
#21
JOURNAL ARTICLE
Emmanuel Ledoult, Matthieu Groh, Bertrand Meresse, Romain Dubois, Jacques Trauet, Elise Toussaint, Marie Delbeke, Eric Hachulla, Louis Terriou, Adèle De Masson, Michele Vasseur, Myriam Labalette, David Launay, Jean-Emmanuel Kahn, Guillaume Lefevre
Not available.
February 8, 2024: Haematologica
https://read.qxmd.com/read/38307204/clinical-picture-outcomes-and-predictors-of-relapse-in-eosinophilia-associated-coronary-vasospasm-data-from-a-european-multicentric-study
#22
JOURNAL ARTICLE
Florent Huang, Lucas Rémi Khellaf, Guillaume Lefèvre, Alvise Berti, Thomas d'Humières, Alessandro Sionis, Albert Ariza Solé, Federica Bello, Juan Andres Bermeo Garrido, Etienne Crickx, Paolo Delvino, Giacomo Emmi, Antoine Gaillet, Gilles Garcia, Pierre-Edouard Gavand, Jean-Louis George, Floriane Gilles, Cécile Golden, Pascal de Groote, Aurélien Guffroy, Nihal Martis, Sara Monti, Pierre Mourlanette, Marc Pineton de Chambrun, Fabrice Prunier, Francesca Regola, Gabriel Seret, Benjamin Terrier, Ludovic Tréfond, Géraud Souteyrand, Olivier Varenne, Filippo Zilio, Franck Haziza, Hakim Benamer, Jean-Emmanuel Kahn, Alexandre Vallée, Matthieu Groh
No abstract text is available yet for this article.
January 31, 2024: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/38304855/b-cell-acute-lymphoblastic-leukemia-associated-with-hypereosinophilia-a-case-report-and-brief-literature-review
#23
Sahar Khosravi, Khatereh Mousavi-Fatemi, Pouyan Ebrahimi, Mohammad Barary, Terence T Sio, Ali Tavakoli Pirzaman
Few cases of B-cell acute lymphoblastic leukemia (B-ALL)-eosinophilia (ALL-eo) association have been reported. The lack or absence of blasts in the peripheral blood smear (PBS) along with urticarial rash, fever, arthralgia, myalgia, sweating, and dyspnea are common features of this condition. Herein, we report a 16-year-old male patient admitted to the emergency department with urticaria and generalized itching. PBS was examined, and eosinophils (90%) were seen in different fields. However, blast cells were not seen in PBS...
2024: SAGE Open Medical Case Reports
https://read.qxmd.com/read/38296476/acute-liver-injury-and-bilateral-pulmonary-artery-thrombosis-due-to-hypereosinophilic-syndrome-a-case-report
#24
JOURNAL ARTICLE
Keishi Ouchi, Hiromasa Okamoto, Jun Inoue, Shigeyuki Kobayashi, Hiroshi Nagai, Daisuke Okamoto, Tomoo Manaka, Yoshihiro Nozawa, Atsushi Masamune
A 46-year-old Japanese man was referred to our hospital because of a marked increase in his eosinophil count (22,870/μL) and elevated liver enzyme levels. Computed tomography (CT) showed thrombi measuring approximately 8 cm in both femoral veins. A liver biopsy revealed eosinophilic infiltration, hepatocyte necrosis, fibrosis, and multiple thrombi. We suspected acute liver injury and deep vein thrombosis associated with hypereosinophilic syndrome and initiated steroids and heparin treatment. Four days after starting treatment, the patient experienced sudden chest pain and cardiopulmonary arrest...
February 1, 2024: Internal Medicine
https://read.qxmd.com/read/38277067/hypereosinophilia-associated-acute-intradialytic-hypotension-a-report-of-three-cases-and-literature-review
#25
JOURNAL ARTICLE
Awaisshafiq Fukumi, Mari Tanaka, Akane Sugae, Yuki Ishida, Hiroko Yamamoto, Tomoka Watanabe, Chiho Fukushima, Miho Miyauchi, Mariko Teragaki, Kotaro Maeda, Yohtaro Takami, Sachio Iwanari, Masaki Ikeda, Hiroya Takeoka
Occasionally, patients undergoing dialysis develop acute severe hypotension that requires interruption of dialysis within minutes of initiating every dialysis session. Although the underlying causes of recurrent intradialytic hypotension are evaluated extensively, including dialysis-associated allergic reactions or other possible causes, the definitive cause is sometimes missed. Dialysis is a life-sustaining procedure; therefore, prompt identification and management of the underlying cause of dialysis intolerance are crucial...
January 26, 2024: CEN Case Reports
https://read.qxmd.com/read/38255222/successful-introduction-of-benralizumab-for-eosinophilic-ascites
#26
Nabil Belfeki, Nouha Ghriss, Souheil Zayet, Faten El Hedhili, Cyrus Moini, Guillaume Lefevre
Eosinophilic ascites is a rare disorder, reported in both adult and pediatric patients, characterized by high eosinophil counts in the peritoneal fluid. Eosinophilic ascites appears as a manifestation of various diseases such as parasitic and fungal infections, malignancy, and hypereosinophilic syndrome. It also represents an uncommon manifestation of eosinophilic gastroenteritis, usually treated with corticosteroids. We present the case of a 16-year-old woman with abdominal distention related to abundant ascites...
January 6, 2024: Biomedicines
https://read.qxmd.com/read/38254826/hematological-neoplasms-with-eosinophilia
#27
REVIEW
Rosario M Morales-Camacho, Teresa Caballero-Velázquez, Juan José Borrero, Ricardo Bernal, Concepción Prats-Martín
Eosinophils in peripheral blood account for 0.3-5% of leukocytes, which is equivalent to 0.05-0.5 × 109 /L. A count above 0.5 × 109 /L is considered to indicate eosinophilia, while a count equal to or above 1.5 × 109 /L is defined as hypereosinophilia. In bone marrow aspirate, eosinophilia is considered when eosinophils make up more than 6% of the total nuclear cells. In daily clinical practice, the most common causes of reactive eosinophilia are non-hematologic, whether they are non-neoplastic (allergic diseases, drugs, infections, or immunological diseases) or neoplastic (solid tumors)...
January 12, 2024: Cancers
https://read.qxmd.com/read/38217096/hypereosinophilic-syndrome-with-eosinophilic-cystitis-in-children
#28
JOURNAL ARTICLE
Mei Shang, Lianjun Gao, Yingying Zhang, Hongfang Ding
No abstract text is available yet for this article.
2024: Pediatrics International: Official Journal of the Japan Pediatric Society
https://read.qxmd.com/read/38203288/-etv6-abl1-positive-myeloid-neoplasm-a-case-of-a-durable-response-to-imatinib-mesylate-without-additional-or-previous-treatment
#29
Maria Teresa Bochicchio, Giovanni Marconi, Carmen Baldazzi, Lorenza Bandini, Francesca Ruggieri, Alessandro Lucchesi, Claudio Agostinelli, Elena Sabattini, Agnese Orsatti, Anna Ferrari, Giorgia Capirossi, Chiara Servili, Andrea Ghelli Luserna di Rorà, Giovanni Martinelli, Giorgia Simonetti, Gianantonio Rosti
ETV6::ABL1 rearranged neoplasms are rare hematological diseases. To date, about 80 cases have been reported, including myeloid and lymphoid leukemias. The ETV6 gene codes for an ETS family transcription factor and several fusion partners have been described. When translocated, ETV6 causes the constitutive activation of the partner genes. Here, we report the case of a 54-year-old woman with a cryptic insertion of the 3' region of ABL1 in the ETV6 gene. The patient was first diagnosed with idiopathic hypereosinophilic syndrome, according to the clinical history, conventional cytogenetics, standard molecular analyses and pathologist description...
December 21, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/38197326/safety-of-dupilumab-in-t2-airways-conditions-focus-on-eosinophilia-across-trials-and-real-life-evidence
#30
JOURNAL ARTICLE
Marco Caminati, Claudio Micheletto, Francesca Norelli, Bianca Olivieri, Giancarlo Ottaviano, Roberto Padoan, Giorgio Piacentini, Michele Schiappoli, Gianenrico Senna, Francesco Menzella
INTRODUCTION: Dupilumab, a monoclonal antibody targeting the IL-4 receptor alpha subunit, effectively blocks both IL-4 and IL-13 mediated pathways. Its introduction has represented a significant advancement in the treatment of severe asthma and other Type 2 (T2) conditions, including nasal polyps, atopic dermatitis, and eosinophilic esophagitis. To date, Dupilumab has demonstrated optimal efficacy and safety profile. AREAS COVERED: The safety profile of dupilumab has been extensively studied, especially for its effects on blood eosinophil count...
January 10, 2024: Expert Opinion on Biological Therapy
https://read.qxmd.com/read/38178804/hypereosinophilic-syndrome-with-intraventricular-thrombus-a-pictorial-presentation
#31
JOURNAL ARTICLE
Amaury Sogorb, Bernhard Gerber, Varnavas Varnavas
No abstract text is available yet for this article.
January 5, 2024: Acta Cardiologica
https://read.qxmd.com/read/38100664/case-study-personalized-oral-low-dose-naltrexone-titration-for-pain-management
#32
JOURNAL ARTICLE
Franklin Rodriguez, Maria Carvalho, Fabiana Banov
Naltrexone is a competitive opioid receptor antagonist indicated to treat opioid and alcohol dependence. In the U.S., naltrexone is commercially available as 50-mg tablets, and the adult dosage strength typically ranges between 50 mg once daily and 100 mg once daily. However, there is evidence to suggest that naltrexone prescribed in low doses, about 1/10th of the daily standard dosage, may be effective in managing a myriad of chronic conditions, including pain refractory to conventional pharmacological treatments...
2023: International Journal of Pharmaceutical Compounding
https://read.qxmd.com/read/38085528/mepolizumab-for-the-treatment-of-eosinophilic-cystitis-reply
#33
JOURNAL ARTICLE
L Trefond, J E Kahn
No abstract text is available yet for this article.
December 12, 2023: Journal of Investigational Allergology & Clinical Immunology
https://read.qxmd.com/read/38077918/retrospective-analysis-of-397-dermatoses-inpatients-associated-with-blood-eosinophilia
#34
JOURNAL ARTICLE
Ying Zhao, Jing Tian, Cuie Gao, Lu Liu, Linxin Pan, Zhiqiang Song
BACKGROUND: Blood eosinophilia is often associated with various dermatoses, such as atopic eczema, urticaria, drug eruption, bullous pemphigoid, and hypereosinophilic syndrome (HES). Differential diagnosis is very challenging due to the similarities of clinical and pathological characteristics. PURPOSE: To investigate and analyze the clinical characteristics of dermatoses associated with blood eosinophilia (DABE) to further optimize disease management. PATIENTS AND METHODS: We conducted a retrospective analysis on 397 DABE patients with blood absolute eosinophil count (AEC) greater than or equal to 0...
2023: Clinical, Cosmetic and Investigational Dermatology
https://read.qxmd.com/read/38073150/an-85-year-old-man-with-fever-dyspnea-and-dry-cough-diagnosed-with-idiopathic-hypereosinophilic-syndrome-successfully-treated-with-high-dose-corticosteroids
#35
JOURNAL ARTICLE
Priya Goyal, Shibba Takkar Chhabra, Rohit Tandon, Bhavuk Jaiswal, Nikita Sharma
BACKGROUND Idiopathic hypereosinophilic syndrome (I-HES) is a rare disease diagnosed as absolute eosinophil count >1500 cells/µl and end-organ involvement attributable to tissue eosinophilia with no secondary cause of underlying eosinophilia. The mean age of presentation for I-HES is 44 years. The skin, lungs, and gastrointestinal (GI) system are most common sites of presenting manifestations, including fatigue, cough, dyspnea, myalgias, angioedema, rash, fever, nausea, and diarrhea. Although cardiac and neurologic symptoms are less common at presentation, they can be life-threatening...
December 11, 2023: American Journal of Case Reports
https://read.qxmd.com/read/38028084/lysozyme-induced-nephropathy-due-to-systemic-granulomatous-disease
#36
Hamza Ashraf, Dariusz Uczkowski, Matthew Stuart
Lysozyme-induced nephropathy is a rare form of acute tubular injury that has almost exclusively been reported in patients with monocytic malignancies. Typically, patients will present in acute renal failure A renal biopsy is necessary to confirm the diagnosis and will demonstrate proximal tubular cells with hypereosinophilic granules, which are periodic acid-Schiff and Jones methenamine silver-positive. Immunohistochemical staining for lysozyme will also be present. The following rare case will describe a case of lysozyme nephropathy in a patient without any underlying hematological malignancy, but instead with systemic granulomatous disease...
November 2023: Clinical Case Reports
https://read.qxmd.com/read/38020823/eosinophilic-colitis-an-uncommon-cause-of-diarrhea-case-report-and-literature-review
#37
Pedro Cardoso, Catarina Elias, Renato Medas, Leila Cardoso, Armando Peixoto, Guilherme Macedo, Jorge Almeida
Eosinophilic colitis and hypereosinophilic syndrome with colic involvement are rare diagnosis that are characterized by wide-ranging gastrointestinal symptoms and idiopathic infiltration of eosinophils in the colon. The diagnostic workup is challenging since there are no standardized criteria. We report a case of a man admitted to the hospital with a history of nonbloody chronic diarrhea. The detailed workup demonstrated blood eosinophilia, and the colonic biopsies revealed extensive eosinophilic infiltration...
November 2023: GE Portuguese Journal of Gastroenterology
https://read.qxmd.com/read/38010473/diagnosis-of-adenoid-cystic-carcinoma-with-striking-tubular-hypereosinophilia-by-myb-and-ewsr1-breakapart-fluorescence-in-situ-hybridization
#38
JOURNAL ARTICLE
Urvashi Yadav, Ria Mahendru, Jyoti Sharma, Aanchal Kakkar
BACKGROUND: Adenoid cystic carcinoma (AdCC), associated with MYB/MYBL1 gene rearrangements, shows epithelial and basaloid myoepithelial cells arranged in tubular, cribriform and solid patterns. Variations from this classic morphology make diagnosis challenging, necessitating molecular testing. AdCC with striking tubular hypereosinophilia (AdCC-STE) is one such recently described histological subtype. METHODS: A 52-year-old female presented with a floor of mouth swelling for two months, diagnosed elsewhere as polymorphous adenocarcinoma (PAC)...
December 2023: Head and Neck Pathology
https://read.qxmd.com/read/38010008/dominant-negative-card11-loss-of-function-variant-presenting-with-hypereosinophilic-syndrome
#39
JOURNAL ARTICLE
Bridget E Wilson, Payge Van Stechelman, Rachel Mariani, Nikita Goswami, Nicole Sidebottom, Cindy S Bauer, Keith A Sacco
No abstract text is available yet for this article.
November 2023: Pediatric Allergy and Immunology
https://read.qxmd.com/read/37999634/hypereosinophilia-during-dupilumab-treatment-in-patients-with-chronic-rhinosinusitis-with-nasal-polyps
#40
JOURNAL ARTICLE
P Kemp, R J L van der Lans, J J Otten, G F J P M Adriaensen, L B L Benoist, M E Cornet, D R Hoven, B Rinia, V Verkest, W J Fokkens, S Reitsma
BACKGROUND: Increased blood eosinophil count (BEC) is common in patients under dupilumab treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). This study investigated the prevalence and consequences of hypereosinophilia and to help define patients at risk. METHODS: Real-life, prospective observational cohort study of patients treated with dupilumab for severe CRSwNP. Eligible patients were adult and biological-naïve (N=334). All BEC values at baseline and during treatment were reported...
November 24, 2023: Rhinology
keyword
keyword
117731
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.